Insider Trading Activity For Bio-Techne Corp (NASDAQ:TECH)
Roger C Lucas , Director of Bio-Techne Corp (NASDAQ:TECH) reportedly Sold 100 shares of the company’s stock at an average price of 114.3 for a total transaction amount of $11,430.00 SEC Form
Insider Trading History For Bio-Techne Corp (NASDAQ:TECH)
On 5/6/2013 Howard V Oconnell, Director, bought 2,361 with an average share price of $65.00 per share and the total transaction amounting to $153,465.00.View SEC Filing
On 11/4/2013 Roger C Lucas, Director, sold 10,000 with an average share price of $87.64 per share and the total transaction amounting to $876,400.00.View SEC Filing
On 11/8/2013 Robert Baumgartner, Director, sold 10,000 with an average share price of $87.00 per share and the total transaction amounting to $870,000.00.View SEC Filing
On 11/13/2013 Randolph Steer, Director, sold 15,000 with an average share price of $86.20 per share and the total transaction amounting to $1,293,000.00.View SEC Filing
On 2/27/2014 Randolph Steer, Director, sold 5,000 with an average share price of $88.78 per share and the total transaction amounting to $443,900.00.View SEC Filing
On 3/4/2014 Karen Holbrook, Director, sold 5,000 with an average share price of $89.83 per share and the total transaction amounting to $449,150.00.View SEC Filing
On 5/7/2014 Howard Oconnell, Director, sold 5,000 with an average share price of $91.00 per share and the total transaction amounting to $455,000.00.View SEC Filing
Analyst Ratings For Bio-Techne Corp (NASDAQ:TECH)
These are 2 Hold Ratings, 4 Buy Ratings .
The current consensus rating for Bio-Techne Corp (NASDAQ:TECH) is Buy (Score: 2.67) with a consensus target price of $123.75 , a potential (5.35% upside)
Analyst Ratings History For Bio-Techne Corp (NASDAQ:TECH)
- On 10/29/2015 Stephens Downgraded rating Overweight to Equal Weight
- On 11/2/2015 Craig Hallum Lower Price Target of rating Buy with a price target of $125.00 to $110.00
- On 8/18/2016 Robert W. Baird Boost Price Target of rating Outperform with a price target of $115.00 to $116.00
- On 11/10/2016 Leerink Swann Initiated Coverage of rating Outperform with a price target of $122.00
- On 3/27/2017 Janney Montgomery Scott Downgraded rating Buy to Neutral
- On 5/3/2017 Citigroup Inc. Reiterated Rating Buy with a price target of $115.00 to $125.00
- On 7/13/2017 Wells Fargo & Company Initiated Coverage of rating Market Perform to Market Perform
Dividend Information For Bio-Techne Corp (NASDAQ:TECH)
Bio-Techne Corp (NASDAQ:TECH) pays an annual dividend of Community Ranking: with a yield of Community Ranking:
Dividend History For Bio-Techne Corp (NASDAQ:TECH)
On 2/5/2013 Bio-Techne Corp announced a quarterly dividend of $0.30 1.74% with an ex dividend date of 2/13/2013 which will be payable on 3/1/2013.
On 4/30/2013 Bio-Techne Corp announced a quarterly dividend of $0.30 1.86% with an ex dividend date of 5/8/2013 which will be payable on 5/24/2013.
On 8/6/2013 Bio-Techne Corp announced a quarterly dividend of $0.30 1.62% with an ex dividend date of 8/14/2013 which will be payable on 8/31/2013.
On 10/31/2013 Bio-Techne Corp announced a quarterly dividend of $0.31 1.4% with an ex dividend date of 11/7/2013 which will be payable on 11/25/2013.
On 2/4/2014 Bio-Techne Corp announced a quarterly dividend of $0.31 1.48% with an ex dividend date of 2/12/2014 which will be payable on 2/28/2014.
On 4/28/2014 Bio-Techne Corp announced a quarterly dividend of $0.31 1.37% with an ex dividend date of 5/7/2014 which will be payable on 5/23/2014.
On 8/11/2014 Bio-Techne Corp announced a quarterly dividend of $0.31 1.31% with an ex dividend date of 8/19/2014 which will be payable on 8/29/2014.
Recent Trading Activity for Bio-Techne Corp (NASDAQ:TECH)
Shares of Bio-Techne Corp closed the previous trading session at 117.47 down -0.07 -0.06% with 100,695 shares trading hands.